cyproheptadine and efavirenz

cyproheptadine has been researched along with efavirenz in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dabaghzadeh, F; Dashti-Khavidaki, S; Ghaeli, P; Khalili, H	1
Akhondzadeh, S; Alimadadi, A; Dabaghzadeh, F; Ghaeli, P; Jafari, S; Khalili, H; Khazaeipour, Z	1

Reviews

2 review(s) available for cyproheptadine and efavirenz

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:18 Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cyproheptadine; Drug Interactions; Evidence-Based Medicine; HIV Seropositivity; Humans; Neurotoxicity Syndromes; Serotonin 5-HT2 Receptor Antagonists	2012

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.

Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:18

Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cyproheptadine; Drug Interactions; Evidence-Based Medicine; HIV Seropositivity; Humans; Neurotoxicity Syndromes; Serotonin 5-HT2 Receptor Antagonists

2012

Trials

1 trial(s) available for cyproheptadine and efavirenz

Article	Year
Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial. AIDS patient care and STDs, 2013, Volume: 27, Issue:3 Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Cyproheptadine; Depression; Double-Blind Method; Female; HIV Infections; Humans; Iran; Male; Mental Disorders; Personality Inventory; Psychiatric Status Rating Scales; Serotonin Antagonists; Socioeconomic Factors; Suicidal Ideation; Surveys and Questionnaires; Treatment Outcome	2013

Article

Year

Cyproheptadine for prevention of neuropsychiatric adverse effects of efavirenz: a randomized clinical trial.

AIDS patient care and STDs, 2013, Volume: 27, Issue:3

Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; Cyproheptadine; Depression; Double-Blind Method; Female; HIV Infections; Humans; Iran; Male; Mental Disorders; Personality Inventory; Psychiatric Status Rating Scales; Serotonin Antagonists; Socioeconomic Factors; Suicidal Ideation; Surveys and Questionnaires; Treatment Outcome

2013

Other Studies

1 other study(ies) available for cyproheptadine and efavirenz

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010